<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39361282</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Time to COVID-19 Vaccination by Language and Country of Origin.</ArticleTitle><Pagination><StartPage>e2437388</StartPage><MedlinePgn>e2437388</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2437388</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2024.37388</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Disparities in COVID-19 vaccination rates by race and ethnicity are well documented. Less is known about primary language and COVID-19 vaccine uptake.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To describe the time to COVID-19 primary series vaccination and booster doses by primary language and country of origin.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This retrospective cohort study included patients aged 6 months or older with at least 1 health encounter from July 1, 2019, to June 30, 2023, at a single health care system serving patients across Minnesota and western Wisconsin.</AbstractText><AbstractText Label="EXPOSURE" NlmCategory="UNASSIGNED">Primary language and country of origin documented in the electronic health record.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Three COVID-19 vaccine coverage outcomes were evaluated: (1) primary series (1 Ad26.COV.S vaccine or 2 mRNA COVID-19 vaccines), (2) first-generation booster (primary series Ad26.COV.S vaccine plus 1 Ad26.COV.S or mRNA COVID-19 vaccine at least 2 months after the second dose or primary series mRNA vaccine plus 1 mRNA vaccine at least 5 months after the second dose), and (3) bivalent booster. Vaccine coverage was described by patient characteristics. Associations of primary language, race and ethnicity, and other patient characteristics with COVID-19 vaccine uptake were evaluated using time-to-event analysis in multivariable Cox proportional hazards regression models, and adjusted hazard ratios (AHRs) with 95% CIs were reported.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There were 1 001 235 patients included (53.7% female). Most patients reported English as a primary language (94.1%) and were born in the US (91.8%). Primary series coverage was 63.7%; first-generation booster coverage, 64.4%; and bivalent booster coverage, 39.5%. Coverage for all outcomes was lower among those with a non-English primary language compared with English as the primary language (56.9% vs 64.1% for primary series; 47.5% vs 65.3% for first-generation booster; 26.2% vs 40.3% for bivalent booster). Those with a non-English primary language had lower COVID-19 vaccine uptake for the primary series (AHR, 0.85; 95% CI, 0.84-0.86), first-generation booster (AHR, 0.74; 95% CI, 0.73-0.75), and bivalent booster (AHR, 0.65; 95% CI, 0.64-0.67) compared with patients with English as their primary language. Non-US-born patients had higher primary series uptake compared with US-born patients (AHR, 1.19; 95% CI, 1.18-1.20) but similar first-generation booster (AHR, 1.01; 95% CI, 0.99-1.02) and bivalent booster (AHR, 1.00; 95% CI, 0.98-1.02) uptake.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">In this retrospective cohort study, patients with a non-English primary language had both lower coverage and delays in receiving COVID-19 vaccines compared with those with English as their primary language. Reporting on language may identify health disparities that can be addressed with language-specific interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Margaret B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>HealthPartners Institute for Medical Education and Research, Bloomington, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrenka</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>HealthPartners Institute for Medical Education and Research, Bloomington, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeSilva</LastName><ForeName>Malini B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>HealthPartners Institute for Medical Education and Research, Bloomington, Minnesota.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="Y">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008910" MajorTopicYN="N" Type="Geographic">Minnesota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014922" MajorTopicYN="N" Type="Geographic">Wisconsin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361282</ArticleId><ArticleId IdType="pmc">PMC11450518</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.37388</ArticleId><ArticleId IdType="pii">2824354</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nguyen KH, Nguyen K, Corlin L, Allen JD, Chung M. Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6-March 29, 2021. Ann Med. 2021;53(1):1419-1428. doi:10.1080/07853890.2021.1957998</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1957998</ArticleId><ArticleId IdType="pmc">PMC8425688</ArticleId><ArticleId IdType="pubmed">34482788</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KH, Anneser E, Toppo A, Allen JD, Scott Parott J, Corlin L. Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States. Vaccine. 2022;40(1):107-113. doi:10.1016/j.vaccine.2021.11.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.11.040</ArticleId><ArticleId IdType="pmc">PMC8598948</ArticleId><ArticleId IdType="pubmed">34852946</ArticleId></ArticleIdList></Reference><Reference><Citation>Shephard HM, Manning SE, Nestoridi E, et al. . Inequities in COVID-19 vaccination coverage among pregnant persons, by disaggregated race and ethnicity—Massachusetts, May 2021-October 2022. MMWR Morb Mortal Wkly Rep. 2023;72(39):1052-1056. doi:10.15585/mmwr.mm7239a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7239a2</ArticleId><ArticleId IdType="pmc">PMC10545434</ArticleId><ArticleId IdType="pubmed">37768877</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MK, Ehresmann KR, Knowlton GS, et al. . Understanding COVID-19 health disparities with birth country and language data. Am J Prev Med. 2023;65(6):993-1002. doi:10.1016/j.amepre.2023.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2023.06.018</ArticleId><ArticleId IdType="pubmed">37406745</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadri NS, Knowlton G, Vazquez Benitez G, et al. . Evaluation of preferred language and timing of COVID-19 vaccine uptake and disease outcomes. JAMA Netw Open. 2023;6(4):e237877. doi:10.1001/jamanetworkopen.2023.7877</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.7877</ArticleId><ArticleId IdType="pmc">PMC10099068</ArticleId><ArticleId IdType="pubmed">37043199</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner A, Rodrigues KK, Mudenge N, et al. . Increasing COVID-19 vaccination coverage for newcomer communities: the importance of disaggregation by language. Am J Trop Med Hyg. 2023;109(1):90-93. doi:10.4269/ajtmh.22-0724</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.22-0724</ArticleId><ArticleId IdType="pmc">PMC10324011</ArticleId><ArticleId IdType="pubmed">37068751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Gurung A, Anglewicz P, et al. . Acceptance of COVID-19 vaccine among refugees in the United States. Public Health Rep. 2021;136(6):774-781. doi:10.1177/00333549211045838</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00333549211045838</ArticleId><ArticleId IdType="pmc">PMC8579383</ArticleId><ArticleId IdType="pubmed">34546812</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas CM, Osterholm MT, Stauffer WM. Critical considerations for COVID-19 vaccination of refugees, immigrants, and migrants. Am J Trop Med Hyg. 2021;104(2):433-435. doi:10.4269/ajtmh.20-1614</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-1614</ArticleId><ArticleId IdType="pmc">PMC7866343</ArticleId><ArticleId IdType="pubmed">33534734</ArticleId></ArticleIdList></Reference><Reference><Citation>Salib Y, Amodei J, Sanchez C, et al. . The COVID-19 vaccination experience of non-English speaking immigrant and refugee communities of color: a community co-created study. Community Health Equity Res Policy. 2024;44(2):177-188. doi:10.1177/2752535X221133140</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2752535X221133140</ArticleId><ArticleId IdType="pmc">PMC9597283</ArticleId><ArticleId IdType="pubmed">36283968</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Levy ME, Naleway AL, et al. . Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—nine states, January-September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(44):1553-1559. doi:10.15585/mmwr.mm7044e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7044e3</ArticleId><ArticleId IdType="pmc">PMC8568092</ArticleId><ArticleId IdType="pubmed">34735426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum HG, Wallace M, Godfrey M, et al. . Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022. MMWR Morb Mortal Wkly Rep. 2022;71(45):1436-1441. doi:10.15585/mmwr.mm7145a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7145a2</ArticleId><ArticleId IdType="pmc">PMC9707353</ArticleId><ArticleId IdType="pubmed">36355612</ArticleId></ArticleIdList></Reference><Reference><Citation>ACIP evidence to recommendations (EtR) for use of bivalent COVID-19 vaccine booster doses under an emergency use authorization. Centers for Disease Control and Prevention. Accessed March 24, 2024. https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-bivalent-booster-etr.html</Citation></Reference><Reference><Citation>R Project for Statistical Computing. A language and environment for statistical computing. Accessed March 24, 2024. https://www.r-project.org/</Citation></Reference><Reference><Citation>Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252-260. doi:10.1016/j.ijid.2021.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati RK, Hur K. Association between limited English proficiency and healthcare access and utilization in California. J Immigr Minor Health. 2022;24(1):95-101. doi:10.1007/s10903-021-01224-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10903-021-01224-5</ArticleId><ArticleId IdType="pubmed">34097162</ArticleId></ArticleIdList></Reference><Reference><Citation>Green AR, Nze C. Language-based inequity in health care: who is the “poor historian”? AMA J Ethics. 2017;19(3):263-271. doi:10.1001/journalofethics.2017.19.3.medu1-1703</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/journalofethics.2017.19.3.medu1-1703</ArticleId><ArticleId IdType="pubmed">28323607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez N, Shi K, Yabroff KR, Han X, Fedewa SA, Nogueira LM. Access to care among adults with limited english proficiency. J Gen Intern Med. 2023;38(3):592-599. doi:10.1007/s11606-022-07690-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07690-3</ArticleId><ArticleId IdType="pmc">PMC9971409</ArticleId><ArticleId IdType="pubmed">35882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurlander D, Lam AG, Dawson-Hahn E, de Acosta D. Advocating for language equity: a community-public health partnership. Front Public Health. 2023;11:1245849. doi:10.3389/fpubh.2023.1245849</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1245849</ArticleId><ArticleId IdType="pmc">PMC10616868</ArticleId><ArticleId IdType="pubmed">37915815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlsen EC, Yankey D, Pezzi C, et al. . Coronavirus disease 2019 (COVID-19) vaccination coverage, intentions, attitudes, and barriers by race/ethnicity, language of interview, and nativity—National Immunization Survey Adult COVID Module, 22 April 2021-29 January 2022. Clin Infect Dis. 2022;75(suppl 2):S182-S192. doi:10.1093/cid/ciac508</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac508</ArticleId><ArticleId IdType="pmc">PMC9278203</ArticleId><ArticleId IdType="pubmed">35737951</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz MI, Marino-Nunez D, Arora VM, Baig AA. Spanish language access to COVID-19 vaccination information and registration in the 10 most populous cities in the USA. J Gen Intern Med. 2022;37(10):2604-2606. doi:10.1007/s11606-021-07325-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07325-z</ArticleId><ArticleId IdType="pmc">PMC8776323</ArticleId><ArticleId IdType="pubmed">35060004</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore R, Rojo MO, Purvis RS, et al. . Overcoming barriers and enhancing facilitators to COVID-19 vaccination in the Hispanic community. BMC Public Health. 2022;22(1):2393. doi:10.1186/s12889-022-14825-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14825-y</ArticleId><ArticleId IdType="pmc">PMC9765355</ArticleId><ArticleId IdType="pubmed">36539771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee K, Markham Shaw C, Brannon GE, et al. . COVID-19 vaccination hesitancies: a Spanish-language focus group analysis in Texas. Health Commun. Published online September 15, 2023. doi:10.1080/10410236.2023.2258310</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10410236.2023.2258310</ArticleId><ArticleId IdType="pubmed">37712138</ArticleId></ArticleIdList></Reference><Reference><Citation>AHA Senate statement on “flatlining care: why immigrants are crucial to bolstering our health care workforce.” American Hospital Association. 2024. Accessed March 24, 2024. https://www.aha.org/testimony/2022-09-14-aha-senate-statement-flatlining-care-why-immigrants-are-crucial-bolstering-our#:~:text=Recent%20studies%20show%20that%2018.2,7%25%20are%20not%20U.S.%20citizens</Citation></Reference><Reference><Citation>Immigrant and refugee health. Centers for Disease Control and Prevention. Accessed March 2, 2024. https://www.cdc.gov/immigrant-refugee-health/hcp/panel-physicians/vaccination.html#cdc_generic_section_9-covid-19-vaccination-requirement</Citation></Reference><Reference><Citation>Baker L, Phillips B, Faherty LJ, Ringel JS, Kranz AM. Racial and ethnic disparities in COVID-19 booster uptake. Health Aff (Millwood). 2022;41(8):1202-1207. doi:10.1377/hlthaff.2022.00287</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2022.00287</ArticleId><ArticleId IdType="pubmed">35914210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>